Squarepoint’s STAAR Surgical STAA Stock Holding History

Squarepoint’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-22,000	Closed	-$884K	–	4479
2023 Q3	$884K	Hold	22,000	–	–	﹤0.01%	2417
2023 Q2	$1.16M	Buy	+22,000	New	+$1.34M	﹤0.01%	2054

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Squarepoint's STAA Position: Q1 2026 in Review

Squarepoint opened a new position in STAAR Surgical (STAA) in Q1 2026: 346,721 shares worth $6.48M. The stake represents 0.01% of the portfolio and ranks #1320 among its holdings. This is a return to the name: Squarepoint previously reported a position in STAA as recently as Q4 2024.

Squarepoint first reported a position in STAA in Q4 2017 and has held it in 20 quarters since. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

Squarepoint held 346,721 shares of STAAR Surgical worth $6.48M as of Q1 2026.
STAAR Surgical was a new Squarepoint position in Q1 2026.
STAAR Surgical made up 0.01% of Squarepoint's portfolio in Q1 2026, its #1320 holding.
Squarepoint first reported a position in STAAR Surgical in Q4 2017 and has held it in 20 quarters since.
187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.